1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory. In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.
Legal status
Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.
See also
- Lysergic acid diethylamide (LSD)
- 1B-LSD
- 1DD-LSD
- 1P-LSD
- 1V-LSD
- ALD-52
- 1cP-AL-LAD
- AL-LAD
- ETH-LAD
- 1P-ETH-LAD
- PRO-LAD
- LSM-775
- LSZ
- O-Acetylpsilocin (4-AcO-DMT)
References
